Bangladesh vs Philippines: The number of people with susceptibility test result for rifampicin
Bangladesh
82,924
in 2021
Philippines
111,868
in 2021
Bangladesh rank
7th
Philippines rank
6th
The number of people with susceptibility test result for rifampicin over time
- Bangladesh
- Philippines
How they compare
Philippines currently reports 111,868 against 82,924 in Bangladesh, a difference of 28,944.
That makes Philippines's figure about 1.3 times Bangladesh's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Bangladesh ahead.
Bangladesh ranks 7th and Philippines ranks 6th of 155 countries.
Across the 2 decades both report, Bangladesh averaged higher in 1 and Philippines in 1.
Head to head by decade
| Decade | Bangladesh | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 39,340 | 32,165 | 7,175 | Bangladesh |
| 2020s | 65,400 | 97,208 | 31,807 | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bangladesh or Philippines?
- Philippines, at 111,868 against 82,924 in Bangladesh as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bangladesh and Philippines?
- 28,944, with Philippines ahead.
- How many years of comparable data are there for Bangladesh and Philippines?
- 5 years are reported by both, from 2017 to 2021.
- How do Bangladesh and Philippines rank globally for the number of people with susceptibility test result for rifampicin?
- Bangladesh ranks 7th and Philippines ranks 6th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.